Qelbree Savings and Support

Learn more about savings and resources available to you with Qelbree.

Qelbree™ (viloxazine extended-release capsules) Copay Savings Card

Pay as little as $20 per prescription

Commercially insured patients may pay as little as $20 per prescription*

Start saving today

*Terms and Conditions apply

Get a sample of Qelbree

Talk to your doctor about requesting a sample of Qelbree. You can make this request in person at your doctor’s office or during a virtual telemedicine appointment. Contact your doctor to set up an appointment and to request a sample of Qelbree.

We’re here to support you

Have questions? Find a single point of contact with Supernus Support and get help with any of the following:

Ways to save on Qelbree
Medication access
Insurance coverage for Qelbree

Reach us Monday - Friday, 8:30AM–6:30PM ET (excluding holidays): 1-866-398-0833

Stay in the know with Qelbree Insider

Sign up to receive personalized tips for supporting your child with ADHD and other helpful resources for you and your child.

Join Qelbree Insider

Qelbree is a non-stimulant treatment for ADHD in children ages 6-17 that is effective all day. Qelbree has been proven effective and safe* in clinical trials, and may be the right treatment option for your child.

*Important: Monitor your child for mood or behavior changes. Your child’s doctor may also monitor for changes in blood pressure and heart rate.

IMPORTANT SAFETY INFORMATION ABOUT QELBREE

INDICATION

Qelbree^® (viloxazine extended-release capsules) is a prescription medicine used to treat ADHD in adults and children 6 years and older.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment [read more] or when the dose is changed. Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

IMPORTANT SAFETY INFORMATION
Qelbree may increase suicidal thoughts and actions, in children and adults with ADHD, especially within the first few months of treatment or when the dose is changed. [read more] Tell your doctor if you or your child have (or if there is a family history of) suicidal thoughts or actions before starting Qelbree. Monitor your or your child’s moods, behaviors, thoughts, and feelings during treatment with Qelbree. Report any new or sudden changes in these symptoms right away.

You should not take Qelbree if you or your child:
Take a medicine for depression called a monoamine oxidase inhibitor (MAOI) or have stopped taking an MAOI in the past 14 days. Also, you or your child should avoid alosetron, duloxetine, ramelteon, tasimelteon, tizanidine, and theophylline.

Qelbree can increase blood pressure and heart rate. Your or your child’s doctor will monitor these vital signs.

Qelbree may cause manic episodes in patients with bipolar disorder. Tell your doctor if you or your child show any signs of mania.

Do not drive or operate heavy machinery until you know how Qelbree will affect you or your child. Qelbree may cause you or your child to feel sleepy or tired.

The most common side effects of Qelbree in patients 6 to 17 years are sleepiness, not feeling hungry, feeling tired, nausea, vomiting, trouble sleeping, and irritability, and in adults, insomnia, headache, sleepiness, tiredness, nausea, decreased appetite, dry mouth, and constipation. These are not all the possible side effects of Qelbree.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please see Medication Guide including Boxed Warning.